Related Experiment Video
Updated: Apr 17, 2026

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
Structural studies reveal thalidomide's mechanism of action and clinical effects: crystal clear or clearly complexed?
Ariel M Ley1, Cindy H Chau, William D Figg
1a Genitourinary Malignancies Branch; Center for Cancer Research; National Cancer Institute; National Institutes of Health ; Bethesda , MD USA.
Abstract:
Another piece of the thalidomide puzzle is unraveled through structural studies of thalidomide and its derivatives bound to its protein target cereblon. Two recent studies published in Nature (Fischer et al.) and Nature Structural & Molecular Biology (Chamberlain et al.) have shed light on the drug's mechanisms of action and its complex biological effects.
More Related Videos
17:28Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
Published on: June 17, 2015
16:02Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
Published on: February 10, 2023
Related Concept Videos
Teratogenicity
Drug Regulation
Drug Toxicity: Dose-Dependent Reactions
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Drugs that Destabilize Microtubules
Drug Toxicity: Risk factors